Paul Stuka is a seasoned investment professional with over 30 years of experience in the industry. He is a Managing Member of Osiris Partners and previously served as a Managing Director at Longwood Partners, where he managed small-cap institutional accounts.( Stuka joined the Board of Directors of InspireMD, Inc. in August 2011 and has served as Chairman of the Board since then, also holding the position of Independent Chairman.( He plays a key role in guiding the strategic direction of InspireMD, a medical device company focused on cardiovascular innovations.

As of March 2022, Stuka continues as Chairman alongside CEO Marvin Slosman and other directors.( Recently, on May 6 and 7, 2026, he increased his stake in InspireMD (NSPR) by purchasing 1,517 shares at $1.12 and 6,378 shares at $1.15 (weighted average), bringing his direct holdings to 531,599 shares.(

Written by Perplexity from public sources.

Filings come from SEC EDGAR. Not investment advice.